A Phase 3, randomized, active-comparator controlled clinical trial to study the contraceptive efficacy and safety of the MK-8342B (etonogestrel + 17β-estradiol) vaginal ring and the levonorgestrel-ethinylestradiol (LNG-EE) 150/30 µg combined oral contraceptive (COC) in healthy women 18 years of age and older, at risk for pregnancy
Latest Information Update: 05 May 2022
Price :
$35 *
At a glance
- Drugs Estradiol/etonogestrel (Primary) ; Ethinylestradiol/levonorgestrel
- Indications Pregnancy
- Focus Adverse reactions; Registrational; Therapeutic Use
- Sponsors Organon
- 16 May 2019 This trial has been completed in Norway, according to European Clinical Trials Database.
- 24 Jan 2017 This trial was discontinued in Germany (end date: 2016-10-06), according to European Clinical Trials Database.
- 25 Nov 2016 This trial was discontinued in Poland (end date: 2016-10-06), according to European Clinical Trials Database.